Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 21, 2011Proceedings of the National Academy of SciencesOpen Access

Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

GBGwendolyn Barceló‐CoblijnHealth Research Institute of the Balearic IslandsMMM. Laura MartínCornell UniversityRARodrigo F.M. de AlmeidaUniversidade Federal do Paraná

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Barceló‐Coblijn et al. (2011) studied this question.

synapsesocial.com/papers/6a78c7da576efb0ddaf84f91https://doi.org/10.1073/pnas.1115484108
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Synthesis and phospholipase C inhibitory activity of D609 diastereomers2002 · 34 citations
  2. 2The hypotensive drug 2-hydroxyoleic acid modifies the structural properties of model membranes2004 · 51 citations
  3. 3Sphingomyelin synthases regulate production of diacylglycerol at the Golgi2008 · 106 citations
  4. 4Pivotal role of dihydrofolate reductase knockdown in the anticancer activity of 2-hydroxyoleic acid2009 · 42 citations